TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Hematopoietic Stem Cells (HSCs) Market Insights, Forecast to 2028

Global Hematopoietic Stem Cells (HSCs) Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 22 August 2022
  • Pages :106
  • Formats:
  • Report Code:SMR-7286420
OfferClick for best price

Best Price: $3920

Hematopoietic Stem Cells HSCs Market Size, Share 2022


Market Analysis and Insights: Global Hematopoietic Stem Cells HSCs Market

The global Hematopoietic Stem Cells HSCs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hematopoietic Stem Cells HSCs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hematopoietic Stem Cells HSCs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hematopoietic Stem Cells HSCs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hematopoietic Stem Cells HSCs market.

Global Hematopoietic Stem Cells HSCs Scope and Market Size

Hematopoietic Stem Cells (HSCs) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Hematopoietic Stem Cells (HSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Leukocyte

Lymphocytes

Red Blood Cells

Platelets

Segment by Application

Blood System Diseases

Autoimmune Diseases

Other

By Company

Kite Pharma Inc.

Thermo Fisher Scientific

PromoCell

CellGenix Technologie Transfer GmbH

Cesca Therapeutics Inc.

R&D Systems

Genlantis

Lonza Group Ltd.

TiGenix N.V.

ScienCell Research Laboratories

China Cord Blood Corporation

Vcanbio

Boyalife

Beike Biotechnology

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Hematopoietic Stem Cells HSCs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Hematopoietic Stem Cells HSCs, with price, sales, revenue, and global market share of Hematopoietic Stem Cells HSCs from 2019 to 2022.

Chapter 3, the Hematopoietic Stem Cells HSCs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hematopoietic Stem Cells HSCs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Hematopoietic Stem Cells HSCs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Hematopoietic Stem Cells HSCs.

Chapter 13, 14, and 15, to describe Hematopoietic Stem Cells HSCs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Hematopoietic Stem Cells HSCs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Hematopoietic Stem Cells (HSCs) Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 106 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Leukocyte
1.2.3 Lymphocytes
1.2.4 Red Blood Cells
1.2.5 Platelets
1.3 Market by Application
1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood System Diseases
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hematopoietic Stem Cells (HSCs) Market Perspective (2017-2028)
2.2 Hematopoietic Stem Cells (HSCs) Growth Trends by Region
2.2.1 Hematopoietic Stem Cells (HSCs) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hematopoietic Stem Cells (HSCs) Historic Market Size by Region (2017-2022)
2.2.3 Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2023-2028)
2.3 Hematopoietic Stem Cells (HSCs) Market Dynamics
2.3.1 Hematopoietic Stem Cells (HSCs) Industry Trends
2.3.2 Hematopoietic Stem Cells (HSCs) Market Drivers
2.3.3 Hematopoietic Stem Cells (HSCs) Market Challenges
2.3.4 Hematopoietic Stem Cells (HSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue
3.1.1 Global Top Hematopoietic Stem Cells (HSCs) Players by Revenue (2017-2022)
3.1.2 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Players (2017-2022)
3.2 Global Hematopoietic Stem Cells (HSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematopoietic Stem Cells (HSCs) Revenue
3.4 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio
3.4.1 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cells (HSCs) Revenue in 2021
3.5 Hematopoietic Stem Cells (HSCs) Key Players Head office and Area Served
3.6 Key Players Hematopoietic Stem Cells (HSCs) Product Solution and Service
3.7 Date of Enter into Hematopoietic Stem Cells (HSCs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematopoietic Stem Cells (HSCs) Breakdown Data by Type
4.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Type (2017-2022)
4.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2023-2028)
5 Hematopoietic Stem Cells (HSCs) Breakdown Data by Application
5.1 Global Hematopoietic Stem Cells (HSCs) Historic Market Size by Application (2017-2022)
5.2 Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hematopoietic Stem Cells (HSCs) Market Size (2017-2028)
6.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type
6.2.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022)
6.2.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028)
6.2.3 North America Hematopoietic Stem Cells (HSCs) Market Share by Type (2017-2028)
6.3 North America Hematopoietic Stem Cells (HSCs) Market Size by Application
6.3.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022)
6.3.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028)
6.3.3 North America Hematopoietic Stem Cells (HSCs) Market Share by Application (2017-2028)
6.4 North America Hematopoietic Stem Cells (HSCs) Market Size by Country
6.4.1 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022)
6.4.2 North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Hematopoietic Stem Cells (HSCs) Market Size (2017-2028)
7.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type
7.2.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022)
7.2.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028)
7.2.3 Europe Hematopoietic Stem Cells (HSCs) Market Share by Type (2017-2028)
7.3 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application
7.3.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022)
7.3.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028)
7.3.3 Europe Hematopoietic Stem Cells (HSCs) Market Share by Application (2017-2028)
7.4 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country
7.4.1 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022)
7.4.2 Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size (2017-2028)
8.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type
8.2.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Share by Type (2017-2028)
8.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application
8.3.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Share by Application (2017-2028)
8.4 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region
8.4.1 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size (2017-2028)
9.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type
9.2.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022)
9.2.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028)
9.2.3 Latin America Hematopoietic Stem Cells (HSCs) Market Share by Type (2017-2028)
9.3 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application
9.3.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022)
9.3.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028)
9.3.3 Latin America Hematopoietic Stem Cells (HSCs) Market Share by Application (2017-2028)
9.4 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country
9.4.1 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022)
9.4.2 Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size (2017-2028)
10.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type
10.2.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Share by Type (2017-2028)
10.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application
10.3.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Share by Application (2017-2028)
10.4 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country
10.4.1 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kite Pharma Inc.
11.1.1 Kite Pharma Inc. Company Details
11.1.2 Kite Pharma Inc. Business Overview
11.1.3 Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.1.4 Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.1.5 Kite Pharma Inc. Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 PromoCell
11.3.1 PromoCell Company Details
11.3.2 PromoCell Business Overview
11.3.3 PromoCell Hematopoietic Stem Cells (HSCs) Introduction
11.3.4 PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.3.5 PromoCell Recent Developments
11.4 CellGenix Technologie Transfer GmbH
11.4.1 CellGenix Technologie Transfer GmbH Company Details
11.4.2 CellGenix Technologie Transfer GmbH Business Overview
11.4.3 CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Introduction
11.4.4 CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.4.5 CellGenix Technologie Transfer GmbH Recent Developments
11.5 Cesca Therapeutics Inc.
11.5.1 Cesca Therapeutics Inc. Company Details
11.5.2 Cesca Therapeutics Inc. Business Overview
11.5.3 Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Introduction
11.5.4 Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.5.5 Cesca Therapeutics Inc. Recent Developments
11.6 R&D Systems
11.6.1 R&D Systems Company Details
11.6.2 R&D Systems Business Overview
11.6.3 R&D Systems Hematopoietic Stem Cells (HSCs) Introduction
11.6.4 R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.6.5 R&D Systems Recent Developments
11.7 Genlantis
11.7.1 Genlantis Company Details
11.7.2 Genlantis Business Overview
11.7.3 Genlantis Hematopoietic Stem Cells (HSCs) Introduction
11.7.4 Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.7.5 Genlantis Recent Developments
11.8 Lonza Group Ltd.
11.8.1 Lonza Group Ltd. Company Details
11.8.2 Lonza Group Ltd. Business Overview
11.8.3 Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Introduction
11.8.4 Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.8.5 Lonza Group Ltd. Recent Developments
11.9 TiGenix N.V.
11.9.1 TiGenix N.V. Company Details
11.9.2 TiGenix N.V. Business Overview
11.9.3 TiGenix N.V. Hematopoietic Stem Cells (HSCs) Introduction
11.9.4 TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.9.5 TiGenix N.V. Recent Developments
11.10 ScienCell Research Laboratories
11.10.1 ScienCell Research Laboratories Company Details
11.10.2 ScienCell Research Laboratories Business Overview
11.10.3 ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Introduction
11.10.4 ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.10.5 ScienCell Research Laboratories Recent Developments
11.11 China Cord Blood Corporation
11.11.1 China Cord Blood Corporation Company Details
11.11.2 China Cord Blood Corporation Business Overview
11.11.3 China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Introduction
11.11.4 China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.11.5 China Cord Blood Corporation Recent Developments
11.12 Vcanbio
11.12.1 Vcanbio Company Details
11.12.2 Vcanbio Business Overview
11.12.3 Vcanbio Hematopoietic Stem Cells (HSCs) Introduction
11.12.4 Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.12.5 Vcanbio Recent Developments
11.13 Boyalife
11.13.1 Boyalife Company Details
11.13.2 Boyalife Business Overview
11.13.3 Boyalife Hematopoietic Stem Cells (HSCs) Introduction
11.13.4 Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.13.5 Boyalife Recent Developments
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Hematopoietic Stem Cells (HSCs) Introduction
11.14.4 Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
11.14.5 Beike Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Leukocyte
Table 3. Key Players of Lymphocytes
Table 4. Key Players of Red Blood Cells
Table 5. Key Players of Platelets
Table 6. Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Hematopoietic Stem Cells (HSCs) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Hematopoietic Stem Cells (HSCs) Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2017-2022)
Table 10. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Hematopoietic Stem Cells (HSCs) Market Share by Region (2023-2028)
Table 12. Hematopoietic Stem Cells (HSCs) Market Trends
Table 13. Hematopoietic Stem Cells (HSCs) Market Drivers
Table 14. Hematopoietic Stem Cells (HSCs) Market Challenges
Table 15. Hematopoietic Stem Cells (HSCs) Market Restraints
Table 16. Global Hematopoietic Stem Cells (HSCs) Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Players (2017-2022)
Table 18. Global Top Hematopoietic Stem Cells (HSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2021)
Table 19. Ranking of Global Top Hematopoietic Stem Cells (HSCs) Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hematopoietic Stem Cells (HSCs) Product Solution and Service
Table 23. Date of Enter into Hematopoietic Stem Cells (HSCs) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2017-2022)
Table 27. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type (2023-2028)
Table 29. Global Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application (2017-2022)
Table 31. Global Hematopoietic Stem Cells (HSCs) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Hematopoietic Stem Cells (HSCs) Revenue Share by Application (2023-2028)
Table 33. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size by Country (2023-2028) & (US$ Million)
Table 63. Kite Pharma Inc. Company Details
Table 64. Kite Pharma Inc. Business Overview
Table 65. Kite Pharma Inc. Hematopoietic Stem Cells (HSCs) Product
Table 66. Kite Pharma Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 67. Kite Pharma Inc. Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Hematopoietic Stem Cells (HSCs) Product
Table 71. Thermo Fisher Scientific Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. PromoCell Company Details
Table 74. PromoCell Business Overview
Table 75. PromoCell Hematopoietic Stem Cells (HSCs) Product
Table 76. PromoCell Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 77. PromoCell Recent Developments
Table 78. CellGenix Technologie Transfer GmbH Company Details
Table 79. CellGenix Technologie Transfer GmbH Business Overview
Table 80. CellGenix Technologie Transfer GmbH Hematopoietic Stem Cells (HSCs) Product
Table 81. CellGenix Technologie Transfer GmbH Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 82. CellGenix Technologie Transfer GmbH Recent Developments
Table 83. Cesca Therapeutics Inc. Company Details
Table 84. Cesca Therapeutics Inc. Business Overview
Table 85. Cesca Therapeutics Inc. Hematopoietic Stem Cells (HSCs) Product
Table 86. Cesca Therapeutics Inc. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 87. Cesca Therapeutics Inc. Recent Developments
Table 88. R&D Systems Company Details
Table 89. R&D Systems Business Overview
Table 90. R&D Systems Hematopoietic Stem Cells (HSCs) Product
Table 91. R&D Systems Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 92. R&D Systems Recent Developments
Table 93. Genlantis Company Details
Table 94. Genlantis Business Overview
Table 95. Genlantis Hematopoietic Stem Cells (HSCs) Product
Table 96. Genlantis Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 97. Genlantis Recent Developments
Table 98. Lonza Group Ltd. Company Details
Table 99. Lonza Group Ltd. Business Overview
Table 100. Lonza Group Ltd. Hematopoietic Stem Cells (HSCs) Product
Table 101. Lonza Group Ltd. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 102. Lonza Group Ltd. Recent Developments
Table 103. TiGenix N.V. Company Details
Table 104. TiGenix N.V. Business Overview
Table 105. TiGenix N.V. Hematopoietic Stem Cells (HSCs) Product
Table 106. TiGenix N.V. Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 107. TiGenix N.V. Recent Developments
Table 108. ScienCell Research Laboratories Company Details
Table 109. ScienCell Research Laboratories Business Overview
Table 110. ScienCell Research Laboratories Hematopoietic Stem Cells (HSCs) Product
Table 111. ScienCell Research Laboratories Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 112. ScienCell Research Laboratories Recent Developments
Table 113. China Cord Blood Corporation Company Details
Table 114. China Cord Blood Corporation Business Overview
Table 115. China Cord Blood Corporation Hematopoietic Stem Cells (HSCs) Product
Table 116. China Cord Blood Corporation Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 117. China Cord Blood Corporation Recent Developments
Table 118. Vcanbio Company Details
Table 119. Vcanbio Business Overview
Table 120. Vcanbio Hematopoietic Stem Cells (HSCs) Product
Table 121. Vcanbio Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 122. Vcanbio Recent Developments
Table 123. Boyalife Company Details
Table 124. Boyalife Business Overview
Table 125. Boyalife Hematopoietic Stem Cells (HSCs) Product
Table 126. Boyalife Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 127. Boyalife Recent Developments
Table 128. Beike Biotechnology Company Details
Table 129. Beike Biotechnology Business Overview
Table 130. Beike Biotechnology Hematopoietic Stem Cells (HSCs) Product
Table 131. Beike Biotechnology Revenue in Hematopoietic Stem Cells (HSCs) Business (2017-2022) & (US$ Million)
Table 132. Beike Biotechnology Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematopoietic Stem Cells (HSCs) Market Share by Type: 2021 VS 2028
Figure 2. Leukocyte Features
Figure 3. Lymphocytes Features
Figure 4. Red Blood Cells Features
Figure 5. Platelets Features
Figure 6. Global Hematopoietic Stem Cells (HSCs) Market Share by Application: 2021 VS 2028
Figure 7. Blood System Diseases Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Other Case Studies
Figure 10. Hematopoietic Stem Cells (HSCs) Report Years Considered
Figure 11. Global Hematopoietic Stem Cells (HSCs) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Hematopoietic Stem Cells (HSCs) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Hematopoietic Stem Cells (HSCs) Market Share by Region: 2021 VS 2028
Figure 14. Global Hematopoietic Stem Cells (HSCs) Market Share by Players in 2021
Figure 15. Global Top Hematopoietic Stem Cells (HSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cells (HSCs) as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Hematopoietic Stem Cells (HSCs) Revenue in 2021
Figure 17. North America Hematopoietic Stem Cells (HSCs) Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Hematopoietic Stem Cells (HSCs) Market Size Market Share by Type (2017-2028)
Figure 19. North America Hematopoietic Stem Cells (HSCs) Market Size Market Share by Application (2017-2028)
Figure 20. North America Hematopoietic Stem Cells (HSCs) Market Size Share by Country (2017-2028)
Figure 21. United States Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Hematopoietic Stem Cells (HSCs) Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Hematopoietic Stem Cells (HSCs) Market Size Market Share by Type (2017-2028)
Figure 25. Europe Hematopoietic Stem Cells (HSCs) Market Size Market Share by Application (2017-2028)
Figure 26. Europe Hematopoietic Stem Cells (HSCs) Market Size Share by Country (2017-2028)
Figure 27. Germany Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Hematopoietic Stem Cells (HSCs) Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Hematopoietic Stem Cells (HSCs) Market Size Share by Region (2017-2028)
Figure 37. China Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Hematopoietic Stem Cells (HSCs) Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Hematopoietic Stem Cells (HSCs) Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Hematopoietic Stem Cells (HSCs) Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Hematopoietic Stem Cells (HSCs) Market Size Share by Country (2017-2028)
Figure 47. Mexico Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Hematopoietic Stem Cells (HSCs) Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Hematopoietic Stem Cells (HSCs) Market Size Share by Country (2017-2028)
Figure 53. Turkey Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Hematopoietic Stem Cells (HSCs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Kite Pharma Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 58. PromoCell Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 59. CellGenix Technologie Transfer GmbH Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 60. Cesca Therapeutics Inc. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 61. R&D Systems Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 62. Genlantis Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 63. Lonza Group Ltd. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 64. TiGenix N.V. Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 65. ScienCell Research Laboratories Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 66. China Cord Blood Corporation Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 67. Vcanbio Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 68. Boyalife Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 69. Beike Biotechnology Revenue Growth Rate in Hematopoietic Stem Cells (HSCs) Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount